Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Camostat and Artemisia Annua vs Placebo in COVID-19 Outpatients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04530617
Recruitment Status : Terminated (Results from the interim analysis)
First Posted : August 28, 2020
Last Update Posted : June 21, 2021
Sponsor:
Information provided by (Responsible Party):
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : June 10, 2021
Actual Study Completion Date : June 10, 2021
Publications of Results:
Ortiz-Brizuela E, Villanueva-Reza M, González-Lara MF, Tamez-Torres KM, Román-Montes CM, Díaz-Mejía BA, Pérez-García E, Olivas-Martínez A, Rajme-López S, Martinez-Guerra BA, de-León-Cividanes NA, Fernández-García OA, Guerrero-Torres L, Torres-González L, Carrera-Patiño FA, Corral-Herrera EA, Hernández-Alemón AN, Tovar-Vargas MLÁ, Serrano-Pinto YG, Espejo-Ortiz CE, Morales-Ortega ML, Lozano-Cruz ÓA, Cárdenas-Fragoso JL, Vidal-Mayo JJ, Hernández-Gilsoul T, Rivero-Sigarroa E, Domínguez-Cherit G, Cervantes-Villar LE, Ramos-Cervantes MDP, Ibarra-González V, Calva-Mercado JJ, Sierra-Madero JG, López-Íñiguez Á, Ochoa-Hein E, Crabtree-Ramírez BE, Galindo-Fraga A, Guerrero-Almeida ML, Ruiz-Palacios GM, Gulías-Herrero A, Sifuentes-Osornio J, Kershenobich-Stalnikowitz D, Ponce-de-León A. CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS OF PATIENTS DIAGNOSED WITH COVID-19 IN A TERTIARY CARE CENTER IN MEXICO CITY: A PROSPECTIVE COHORT STUDY. Rev Invest Clin. 2020;72(3):165-177. doi: 10.24875/RIC.20000211. Erratum in: Rev Invest Clin. 2020;72(4):252-258.

Other Publications: